RECENT NEWS

Flow Eighteen38 and FairJourney Biologics (FJB) have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools for the Hans Clevers group.

Bio-Rad Laboratories, a leader in life science research and clinical diagnostic products, has launched the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.

Pharmaceutical and biotechnology laboratories performing high-throughput screening, high-content screening and molecular cell biology can now benefit from a series of new automated incubators and storage solutions.

Anion dysregulation occurs in many diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo with tools to help analyse the effects at the molecular level.

British In Vitro Diagnostics Association (BIVDA) Chief Executive Doris-Ann Williams and Chief Operating Officer Helen Dent have commented on the publication of the Health and Care Bill.

The ShuttlePouch range of leakproof pouches is designed to carry individual 95-kPa pressure differential certified blood or urine specimen tubes, and include absorbent material inside for convenient compliance to UN3373 packaging requirements.

Laboratories at four trusts, in Buckinghamshire, Milton Keynes, Oxfordshire and Swindon, will use WinPath Enterprise to deliver a consistent, high-quality and equitable service and build a platform for innovation.

Consultant biomedical scientist roles are no longer the rarity they once were. RCPath/IBMS examinations in cellular pathology have begun to open career pathways that will allow these roles to become more commonplace over time, as Guy Orchard explains

SHOT and the MHRA will hold a joint webinar on 19 May, 1300–1400 BST, on the importance of learning from Near Miss events and the principles of Investigating Incidents. It will also include illustrative cases to highlight key learning points.

Thermo Fisher Scientific has launched a CO2 incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, addressing the need for high-performance incubation systems that meet stringent cleanroom and cGMP standards.

Beckman Coulter has announced the European launch of the DxA 5000 Fit, a workflow automation solution designed to fit into medium-sized laboratories that run fewer than 5000 tests a day.

CytoSMART Technologies has announced the release of its first fluorescence cell counter. The CytoSMART Exact FL is an automated, dual fluorescence cell counter with an expanded field of view and performance.

A test that uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to recent research.

LIOFeron-TB/LTBI is an in vitro blood IGRA useful in the detection of Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB), and is intended for use in conjunction with other medical and diagnostic evaluations.

Sysmex UK has recently launched the new CN-Series of analysers, designed to provide a powerful solution and to deliver answers to laboratory haemostasis testing requirements of productivity, services, analytical and operational performance.

The Randox Discovery, an innovative diagnostic analyser that can consolidate molecular and immunoassay testing on one compact benchtop platform, has received the 2021 Red Dot Award for High Design Quality.

AnteoTech has announced that its EuGeni Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received CE-mark registration as the company looks to progress with European distribution.

INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate various conditions to test adherent cell cultures.

A study led by The Institute of Cancer Research (ICR) researchers has revealed that death from infection in patients with chronic lymphocytic leukaemia (CLL) is associated with certain gene mutations.

A partnership that will transform pathology services and help to improve the quality of patient care across South East London has gone live.